Biological Threat Detection Via Host Gene Expression Profiling. Biological Threat Detection Via Host Gene Expression Profiling.

Biological Threat Detection Via Host Gene Expression Profiling‪.‬

Clinical Chemistry 2003, July, 49, 7

    • 2,99 €
    • 2,99 €

Beschreibung des Verlags

The task of detecting biological threats is far more complicated than monitoring for other weapons of mass destruction. Measuring and quantifying radiation and chromatographic profiles indicative of nuclear and chemical threats, respectively, are relatively straightforward compared with the detection of biological weapon threats amid the tremendous biological background that comprises our environment. Most of the current biological warfare and environmental agent detection systems in field use or under prototype development rely on structural recognition approaches to identify anticipated agents or rely on "gold standard" culture conditions. Such assays, based primarily on antibodies, are highly specific for anticipated targets but provide only partial information concerning the pathogenicity of the threat. Current systems the military has implemented for threat identification have performed with limited success. In fact, the Pentagon Inspector General has criticized the "Joint Biological Point Detection System" for erratic limited performance (1). In addition, it is unclear how such an approach is applicable to the civilian population, where mass deployment of point detectors is not a feasible solution. Even with ideal detectors, proximity to a biological threat does not guarantee infection or illness. For threats such as Bacillus anthracis, the ability to preemptively treat individuals who were near dissemination sources with antibiotics is an option, if the dissemination source can be identified. Of further concern, a report has been published of a B. anthracis vaccine strain that had been engineered by Russian scientists to resist tetracycline antibiotics (2), raising the possibility that a quinolone-resistant B. anthracis could emerge as a biological weapon threat. Thus, not all biological threats can be treated as readily as during recent events, and there is a critical need to be able to quickly discern those individuals who are ill as a result of a bioagent etiology and to yield insight to the severity of illness.

GENRE
Wissenschaft und Natur
ERSCHIENEN
2003
1. Juli
SPRACHE
EN
Englisch
UMFANG
15
Seiten
VERLAG
American Association for Clinical Chemistry, Inc.
ANBIETERINFO
The Gale Group, Inc., a Delaware corporation and an affiliate of Cengage Learning, Inc.
GRÖSSE
171,6
 kB
Gene Discovery for Disease Models Gene Discovery for Disease Models
2011
Chemical Diagnostics Chemical Diagnostics
2013
Molecular Analysis and Genome Discovery Molecular Analysis and Genome Discovery
2011
Omics Approaches, Technologies And Applications Omics Approaches, Technologies And Applications
2019
Systems Biological Approaches in Infectious Diseases Systems Biological Approaches in Infectious Diseases
2007
Integration of Omics Approaches and Systems Biology for Clinical Applications Integration of Omics Approaches and Systems Biology for Clinical Applications
2018
Highly Sensitive Immunoprecipitation Method for Extracting and Concentrating Low-Abundance Proteins from Human Serum (Technical Briefs) Highly Sensitive Immunoprecipitation Method for Extracting and Concentrating Low-Abundance Proteins from Human Serum (Technical Briefs)
2005
Longitudinal Concentrations of Vitamin [B.Sub.12] and Vitamin [B.Sub.12]-Binding Proteins During Uncomplicated Pregnancy (General Clinical Chemistry) (Clinical Report) Longitudinal Concentrations of Vitamin [B.Sub.12] and Vitamin [B.Sub.12]-Binding Proteins During Uncomplicated Pregnancy (General Clinical Chemistry) (Clinical Report)
2002
Multicenter Characterization and Validation of the Intron-8 Poly(T) Tract (IVS8-T) Status in 25 Coriell Cell Repository Cystic Fibrosis Reference Cell Lines for Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene Mutation Assays (Technical Briefs) Multicenter Characterization and Validation of the Intron-8 Poly(T) Tract (IVS8-T) Status in 25 Coriell Cell Repository Cystic Fibrosis Reference Cell Lines for Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene Mutation Assays (Technical Briefs)
2004
Immunoassay Standardization: Is It Possible, Who Is Responsible, Who Is Capable?(Opinion) (Clinical Report) Immunoassay Standardization: Is It Possible, Who Is Responsible, Who Is Capable?(Opinion) (Clinical Report)
2001
A Conversation with Elizabeth Blackburn (Interview) A Conversation with Elizabeth Blackburn (Interview)
2009
The Evolution of Immunoassay As Seen Through the Journal Clinical Chemistry (Aacc 50th Years Anniversary Retrospective) The Evolution of Immunoassay As Seen Through the Journal Clinical Chemistry (Aacc 50th Years Anniversary Retrospective)
1998